tiprankstipranks
Trending News
More News >
TherapeuticsMD (TXMD)
NASDAQ:TXMD

TherapeuticsMD (TXMD) Price & Analysis

Compare
2,242 Followers

TXMD Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.48%4.48%21.63%69.20%
21.63% Other Institutional Investors
69.20% Public Companies and Individual Investors

TXMD FAQ

What was TherapeuticsMD’s price range in the past 12 months?
TherapeuticsMD lowest stock price was $0.70 and its highest was $2.44 in the past 12 months.
    What is TherapeuticsMD’s market cap?
    TherapeuticsMD’s market cap is $12.96M.
      When is TherapeuticsMD’s upcoming earnings report date?
      TherapeuticsMD’s upcoming earnings report date is Aug 18, 2025 which is in 46 days.
        How were TherapeuticsMD’s earnings last quarter?
        TherapeuticsMD released its earnings results on May 13, 2025. The company reported -$0.056 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.056.
          Is TherapeuticsMD overvalued?
          According to Wall Street analysts TherapeuticsMD’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does TherapeuticsMD pay dividends?
            TherapeuticsMD does not currently pay dividends.
            What is TherapeuticsMD’s EPS estimate?
            TherapeuticsMD’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does TherapeuticsMD have?
            TherapeuticsMD has 11,574,362 shares outstanding.
              What happened to TherapeuticsMD’s price movement after its last earnings report?
              TherapeuticsMD reported an EPS of -$0.056 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.947%.
                Which hedge fund is a major shareholder of TherapeuticsMD?
                Currently, no hedge funds are holding shares in TXMD

                Company Description

                TherapeuticsMD

                TherapeuticsMD (TXMD) is a healthcare company focused on developing and commercializing innovative solutions for women's health. The company operates within the pharmaceutical sector, offering a range of products designed to address various stages of women's health, including menopause, pregnancy prevention, and hormone therapy. Their core products include hormone replacement therapies and prenatal vitamins, aimed at improving the overall well-being of women.
                Similar Stocks
                Company
                Price & Change
                Follow
                Prophase Labs
                Aytu BioScience
                Kala Pharmaceuticals
                Cosmos Holdings
                Biofrontera
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis